- Home
- CRVS vs HNVR Comparison
CRVS vs HNVR Comparison
Compare CRVS & HNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- HNVR
- Stock Information
- Founded
- CRVS 2014
- HNVR 2008
- Country
- CRVS United States
- HNVR United States
- Employees
- CRVS N/A
- HNVR N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- HNVR Commercial Banks
- Sector
- CRVS Health Care
- HNVR Finance
- Exchange
- CRVS Nasdaq
- HNVR Nasdaq
- Market Cap
- CRVS 161.4M
- HNVR 128.7M
- IPO Year
- CRVS 2016
- HNVR 2022
- Fundamental
- Price
- CRVS $4.03
- HNVR $17.45
- Analyst Decision
- CRVS Buy
- HNVR Buy
- Analyst Count
- CRVS 3
- HNVR 1
- Target Price
- CRVS $5.75
- HNVR $20.00
- AVG Volume (30 Days)
- CRVS 405.1K
- HNVR 2.6K
- Earning Date
- CRVS 08-06-2024
- HNVR 10-24-2024
- Dividend Yield
- CRVS N/A
- HNVR 2.29%
- EPS Growth
- CRVS N/A
- HNVR N/A
- EPS
- CRVS N/A
- HNVR 1.96
- Revenue
- CRVS N/A
- HNVR $61,909,000.00
- Revenue This Year
- CRVS N/A
- HNVR N/A
- Revenue Next Year
- CRVS N/A
- HNVR $16.93
- P/E Ratio
- CRVS N/A
- HNVR $8.89
- Revenue Growth
- CRVS N/A
- HNVR N/A
- 52 Week Low
- CRVS $1.05
- HNVR $13.62
- 52 Week High
- CRVS $4.75
- HNVR $18.86
- Technical
- Relative Strength Index (RSI)
- CRVS 58.05
- HNVR 50.24
- Support Level
- CRVS $3.90
- HNVR $16.90
- Resistance Level
- CRVS $4.75
- HNVR $18.12
- Average True Range (ATR)
- CRVS 0.30
- HNVR 0.30
- MACD
- CRVS -0.08
- HNVR -0.05
- Stochastic Oscillator
- CRVS 18.18
- HNVR 52.48
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About HNVR Hanover Bancorp Inc.
Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.